Evidence map›Paper›PMID 14573665›Full record

ArticleInfection and immunity2003

Human neutrophil chemotaxis is modulated by capsule and O antigen from an extraintestinal pathogenic Escherichia coli strain.

Thomas A Russo, Bruce A Davidson, Diana M Topolnycky, Ruth Olson, Stacy A Morrill, Paul R Knight, Philip M Murphy

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 53% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Thomas A RussoDepartment of Medicine, The Witebsky Center for Microbial Pathogenesis. Veterans Administration Western New York Healthcare System, University at Buffalo, Buffalo, New York 14214, USA. trusso@acsu.buffalo.edu
Bruce A Davidson
Diana M Topolnycky
Ruth Olson
Stacy A Morrill
Paul R Knight
Philip M Murphy
University at Buffalo, State University of New York · USNational Institutes of Health · USVA Western New York Healthcare System · US

Funding

MOLECULAR ANALYSIS OF NEUTROPHIL ACTIVATION BY CHEMOATTRACTANTSZ01AI000615 · NIAID · NIAID EXTRAMURAL ACTIVITIES · PI MURPHY, PHILIP · 1991 to 2008
$7.1M
PATHOGENESIS OF ASPIRATION PNEUMONITISR01HL048889 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI KNIGHT III, PAUL R · 1996 to 2011
$3.2M
Host response to post-operative pneumoniaR01AI046534 · NIAID · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI KNIGHT, PAUL R · 2001 to 2005
$2.2M
BACTERIAL MODULATION OF LUNG INFLAMMATORY RESPONSER01HL069763 · NHLBI · STATE UNIVERSITY OF NEW YORK AT BUFFALO · PI RUSSO, THOMAS A · 2001 to 2004
$1.4M
NHLBI NIH HHS HL48889NHLBI NIH HHS HL69763NHLBI NIH HHS R01 HL048889NHLBI NIH HHS R01 HL069763NIAID NIH HHS AI46534NIAID NIH HHS R01 AI046534
6 · The paper itself

Abstract

Gram-negative enteric bacilli, such as Escherichia coli, are common causes of nosocomial pneumonia. The interaction between pulmonary neutrophils and the infecting pathogen is a critical step in determining the outcome. Previous studies from our laboratory, for which a rat model of pneumonia was used, established that pulmonary neutrophil recruitment was modulated by the E. coli virulence factors capsule and O-specific antigen. To begin to understand the mechanism by which this recruitment occurs, we conducted in vitro and ex vivo chemotaxis assays, for which we used a clinically relevant E. coli isolate (CP9) and isogenic derivatives that were deficient in only the O antigen (CP921) or capsule (CP9.137) as chemoattractants with or without the high-affinity N-formylmethionyl-leucyl-phenylalanine receptor antagonist N-tert-butoxycarbonyl-methionine-leucine-phenylalanine (N-t-BOC). Given that only live E. coli was used for the initial in vitro chemotaxis assays, it was predicted that only N-t-BOC-sensitive chemotaxis would occur. However, both N-t-BOC-sensitive and -insensitive chemotaxis was observed. N-t-BOC-insensitive chemotaxis was mediated in part by interleukin 8, which was produced by neutrophils that had migrated toward E. coli. N-t-BOC-insensitive chemotaxis was only observed when live E. coli bacteria, not cell-free E. coli culture supernatants, were used as chemoattractants, suggesting that a direct E. coli-neutrophil interaction was necessary. The presence of both capsule and O antigen diminished total, N-t-BOC-sensitive, and N-t-BOC-insensitive neutrophil chemotaxis in vitro. The presence of capsule significantly decreased total, N-t-BOC-sensitive, and N-t-BOC-insensitive neutrophil chemotaxis ex vivo when cell-free bronchoalveolar lavage fluid from infected rats was used as the source of chemotactic factors. These effects of E. coli capsule and O antigen on neutrophil chemotaxis are novel, and they expand our understanding of the mechanisms by which these virulence traits contribute to the pathogenesis of gram-negative pneumonia and other extraintestinal infections.

Indexed as

Chemotaxis, LeukocyteAnimalsBacterial CapsulesEscherichia coliHumansInterleukin-8NeutrophilsO AntigensOligopeptidesRatsRats, Long-EvansInterleukin-8O AntigensOligopeptidest-butyloxycarbonyl-methionyl-leucyl-phenylalanine

Identifiers

PMID14573665
PMCPMC219585
OpenAlexW2096058332

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.